U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07892625) titled 'A Phase I Study of HS-20093 in Combination With ZG006 With or Without Adebrelimab in Patients With ES-SCLC' on Aug. 13.
Brief Summary: This is a multicenter, open-label Phase I study evaluating the safety, tolerability, pharmacokinetic, and efficacy of Intravenous HS-20093 in combination with ZG006 with or without adebrelimab in patients with extensive-stage small cell lung cancer.
Study Start Date: Nov. 15
Study Type: INTERVENTIONAL
Condition:
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Intervention:
DRUG: HS-20093 for Injection
The patient will be treated with HS-20093.
DRUG: ZG006
The patient will be treated with ZG...